Project Grant K01DK140206
- This Project Grant award of $109,076, issued March 3, 2026, supports research under the National Institute on Aging's Aging Research program (CFDA 93.866). The research, conducted at Weill Medical College of Cornell University in New York, investigates vulnerable cell populations in aging-induced circadian clock remodeling and disruption through high-throughput single-nucleus RNA sequencing (snRNA-seq) of flash-frozen tissues from mice. The primary deliverables include comprehensive...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $386,900.00 to the University of Texas Health Science Center at Houston (UTHealth) to study the role of the circadian clock and retinoid acid receptor-related orphan receptor (ROR) proteins in regulating metabolic function and healthy aging. The key objectives are to: 1) Evaluate the impact of ROR proteins on healthspan and lifespan using mice with skeletal muscle-specific ROR knockout, 2)...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to investigate the relationship between circadian disruption and cardiometabolic risk during the transition from adolescence to young adulthood. The $691,124 award to the Regents of the University of Michigan will leverage existing data on sleep/wake patterns and cardiometabolic health biomarkers to test the hypothesis that persistent circadian disruption is linked to...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $281,560 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2027. The award supports mathematical modeling research examining peripheral metabolic circadian rhythms and their implications for managing circadian rhythm disruption caused by shift work and transmeridian travel....
- Federal Project Grant Award Summary The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center received a $743,388 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on August 15, 2025, with completion expected by May 31, 2029. The institute will conduct two randomized, placebo-controlled trials enrolling 48 adults (24 women) aged 22-45 years to investigate the mechanisms...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $731,850 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 5, 2025, with completion targeted for May 31, 2029. The research project investigates the bioenergetics mechanisms underlying time-restricted feeding (TRF) and its metabolic benefits,...
- This $146,816.00 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research training to investigate the role of the muscle circadian clock in cancer cachexia. The overarching goal is to define how disruption of the muscle clock may serve as a modifier for the development and progression of cancer-induced muscle weakness and wasting. Key...
- This Project Grant award of $604,853 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund research at Rockefeller University to elucidate the genetic determinants of human brown adipose tissue (BAT) function. The goal is to develop a better understanding of how BAT, which can protect against obesity and associated metabolic diseases, is regulated in humans. The research will leverage...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $721,041 through the Cardiovascular Diseases Research program (CFDA 93.837) to The Research Foundation for the State University of New York on June 5, 2025, for a project examining the role of cardiac circadian clock misalignment in promoting arrhythmias. The research will be conducted through March 31, 2030, at facilities in New York and will investigate the mechanisms by which chronic ischemia creates...
- This $162,512 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to examine how the circadian clock influences reproductive behavior and sexual drive in mice. The project, conducted by the Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, MA, aims to determine if the timing of peak sexual behavior between males and females impacts...
CIRCADIAN REGULATION OF MOLECULAR AND SYSTEMIC ADIPOSE TISSUE FUNCTION IN HUMANS - PROJECT SUMMARY THE MAMMALIAN CIRCADIAN SYSTEM REGULATES METABOLIC PROCESSES OVER A 24-HOUR CYCLE AND MOLECULAR CIRCADIAN CLOCKS CONTROL FUNCTIONAL TISSUE SPECIFIC AND CELL AUTONOMOUS OSCILLATIONS. ADIPOCYTES, THE PRIMARY CELL TYPE IN ADIPOSE TISSUE, ARE CENTRAL TO REGULATING FREE FATTY ACID METABOLISM; DYSREGULATION OF FREE FATTY ACID RELEASE FROM ADIPOCYTES (I.E. LIPOLYSIS) IS CENTRAL TO THE PATHOPHYSIOLOGY OF OBESITY AND CONTRIBUTES TO LIPOTOXICITY IN OTHER TISSUES SUCH AS PANCREAS, LIVER, AND MUSCLE. SHIFT WORKERS HAVE DISRUPTIONS IN THE CIRCADIAN SYSTEM AND ARE AT INCREASED RISK OF OBESITY AND METABOLIC DISEASE. ADIPOCYTES HAVE A CELL AUTONOMOUS CYCLING MOLECULAR CIRCADIAN CLOCK AND THE LITERATURE SUGGESTS THAT ADIPOCYTE METABOLISM AND LIPOLYSIS PATHWAYS ARE REGULATED BY CELL INTRINSIC CIRCADIAN RHYTHMS THAT ARE ALTERED IN OBESITY. HOWEVER, ADIPOCYTES ARE HIGHLY RESPONSIVE TO BOTH NUTRIENT DELIVERY AND SYSTEMIC HORMONAL SIGNALS DRIVEN BY INTERMITTENT MEAL INTAKE, MAKING MANY SECRETED ADIPOCYTE PRODUCTS APPEAR RHYTHMIC OVER A 24 H FASTING/FEEDING CYCLE. THEREFORE, THE RELATIVE CONTROL OF ADIPOSE TISSUE BY FEEDING VERSUS MOLECULAR CLOCK DRIVEN MECHANISMS IN HUMANS IS NOT UNDERSTOOD. AS SUCH, THE OVERALL GOAL OF THIS APPLICATION IS TO DEFINE THE MOLECULAR AND SYSTEMIC ROLE OF INTRINSIC ADIPOCYTE MOLECULAR CIRCADIAN CLOCK AND HOW THIS IS IMPACTED BY OBESITY IN HUMANS. IN THIS CONTEXT, AIM 1 WILL ESTABLISH WHETHER HUMAN SUBCUTANEOUS ADIPOSE TISSUE EXHIBITS AUTONOMOUS SYSTEMIC AND MOLECULAR CIRCADIAN RHYTHMICITY INDEPENDENT OF DIURNAL NUTRIENT DELIVERY IN VIVO IN NORMAL WEIGHT HUMANS. AIM 2 WILL INTERROGATE WHETHER OBESITY ALTERS ADIPOCYTE SPECIFIC RHYTHMS IN CIRCADIAN AND LIPOLYSIS GENES AND IS RELATED TO MEASURES OF SYSTEMIC ADIPOSE TISSUE FUNCTION. FINALLY, AIM 3 WILL INTERROGATE THE IMPACT OF FEEDING REGIME AND OBESITY ON THE ADIPOCYTE SPECIFIC CISTROME OF CORE CIRCADIAN CLOCK TRANSCRIPTION FACTORS ALLOWING A MORE COMPLETE UNDERSTANDING OF GENOMIC REGULATION OF ADIPOCYTE CLOCK. THIS WORK WILL BE THE FIRST WORK TO ADDRESS THE RELATIVE CONTRIBUTION OF INTRINSIC ADIPOCYTE CIRCADIAN CLOCK DURING CONTINUOUS FEEDING VERSUS ADIPOCYTE FUNCTION DRIVEN BY INTERMITTENT FOOD INTAKE IN HUMANS AND INTERROGATE CIRCADIAN CLOCK IN THE CONTEXT OF OBESITY. ANSWERING THESE FUNDAMENTAL QUESTIONS IS ESSENTIAL TO UNDERSTANDING WHETHER DISRUPTIONS IN CIRCADIAN MOLECULAR CLOCKS CONTRIBUTE TO METABOLIC ABNORMALITIES IN OBESITY AND THESE STUDIES WILL PROVIDE A REGULATORY PARADIGM FOR CIRCADIAN CLOCK IN ADIPOCYTES. IMPORTANTLY, THESE PROPOSED RESEARCH ACTIVITIES WITH AN OUTSTANDING MENTORSHIP TEAM AND THE INTELLECTUALLY ENRICHING ENVIRONMENT AT MAYO CLINIC WILL BUILD UPON THE APPLICANT'S TRAINING AND PROVIDE OPPORTUNITIES TO EXPAND HER CLINICAL TRANSLATIONAL KNOWLEDGE AND SKILLSET CULMINATING IN THE DEVELOPMENT OF A RESEARCH NICHE FOR THE APPLICANT.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $172.0k | 5/29/25 | ||
| Not listed | $173.5k | 8/1/24 | ||
| Not listed | $173.5k | 8/1/24 |